Clopidogrel Bisulfate Tablets
This product is indicated for the prevention of atherothrombosis events in: 1. Patients with recent myocardial infarction, recent ischemic stroke or confirmed peripheral arterial disease. 2. Patients with acute coronary syndrome. 3. Patients with non-ST-segment elevation acute coronary syndrome (including unstable angina or non-Q wave myocardial infarction), including patients with stent placement following percutaneous coronary intervention. 4. Patients with ST-segment elevation acute coronary syndrome.
Product Category：
Product Description
[Product Name] Pragoli®
[Generic Name] Clopidogrel Bisulfate Tablets
[Approval No.] Imported Drug Registration Specification: JX20170314
[Specification] Imported Drug Registration No.: H20180074
[Dosage and Administration] 75 mg once daily, taken orally with or without food
[Age of Use] Over 18 years old, see package insert for details
[Strength] 75 mg*20 tablets/carton
[Storage] Store in airtight containers in a dry place, protected from light
[Shelf Life] 36 months
[Manufacturer] Dr. Reddy's Laboratories Ltd.
[China General Distributor] Shenzhen Foncoo Pharmaceutical Co., Ltd.
ONLINE MESSAGE
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No. 1001, Xueyuan Avenue, Changyuan Community, Taoyuan Street, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED